157 related articles for article (PubMed ID: 2545640)
1. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.
Ryttig KR; Tellnes G; Haegh L; Bøe E; Fagerthun H
Int J Obes; 1989; 13(2):165-71. PubMed ID: 2545640
[TBL] [Abstract][Full Text] [Related]
2. Weight reduction with dietary fibre supplements. Results of two double-blind randomized studies.
Rössner S; von Zweigbergk D; Ohlin A; Ryttig K
Acta Med Scand; 1987; 222(1):83-8. PubMed ID: 2820202
[TBL] [Abstract][Full Text] [Related]
3. Effects of a dietary fibre supplement to a weight reduction programme on blood pressure. A randomized, double-blind, placebo-controlled study.
Rössner S; Andersson IL; Ryttig K
Acta Med Scand; 1988; 223(4):353-7. PubMed ID: 2835892
[TBL] [Abstract][Full Text] [Related]
4. Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial.
Rigaud D; Ryttig KR; Angel LA; Apfelbaum M
Int J Obes; 1990 Sep; 14(9):763-9. PubMed ID: 2172178
[TBL] [Abstract][Full Text] [Related]
5. The influence of a high-fibre diet on body weight, serum lipids and blood pressure in slightly overweight persons. A randomized, double-blind, placebo-controlled investigation with diet and fibre tablets (DumoVital).
Solum TT; Ryttig KR; Solum E; Larsen S
Int J Obes; 1987; 11 Suppl 1():67-71. PubMed ID: 3032827
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of fibre supplement and reduced energy intake on body weight and blood lipids in overweight subjects.
Birketvedt GS; Aaseth J; Florholmen JR; Ryttig K
Acta Medica (Hradec Kralove); 2000; 43(4):129-32. PubMed ID: 11294130
[TBL] [Abstract][Full Text] [Related]
7. Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation.
Astrup A; Vrist E; Quaade F
Int J Obes; 1990 Feb; 14(2):105-12. PubMed ID: 2160441
[TBL] [Abstract][Full Text] [Related]
8. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
9. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
10. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
Pal S; Khossousi A; Binns C; Dhaliwal S; Ellis V
Br J Nutr; 2011 Jan; 105(1):90-100. PubMed ID: 20727237
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
[TBL] [Abstract][Full Text] [Related]
12. Effects of a moderate dietary fibre supplement on hunger rating, energy input and faecal energy output in young, healthy volunteers. A randomized, double-blind, cross-over trial.
Rigaud D; Ryttig KR; Leeds AR; Bard D; Apfelbaum M
Int J Obes; 1987; 11 Suppl 1():73-8. PubMed ID: 3032828
[TBL] [Abstract][Full Text] [Related]
13. A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial.
Eliasson K; Ryttig KR; Hylander B; Rössner S
J Hypertens; 1992 Feb; 10(2):195-9. PubMed ID: 1313484
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
15. [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial].
Toubro S; Hansen DL; Hilsted JC; Porsborg PA; Astrup AV;
Ugeskr Laeger; 2001 May; 163(21):2935-40. PubMed ID: 11402974
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 3-month supplementation with a novel soluble highly viscous polysaccharide on anthropometry and blood lipids in nondieting overweight or obese adults.
Lyon M; Wood S; Pelletier X; Donazzolo Y; Gahler R; Bellisle F
J Hum Nutr Diet; 2011 Aug; 24(4):351-9. PubMed ID: 21414045
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management.
Diepvens K; Soenen S; Steijns J; Arnold M; Westerterp-Plantenga M
Int J Obes (Lond); 2007 Jun; 31(6):942-9. PubMed ID: 17299383
[TBL] [Abstract][Full Text] [Related]
18. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
19. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
20. The effects of 12-week psyllium fibre supplementation or healthy diet on blood pressure and arterial stiffness in overweight and obese individuals.
Pal S; Khossousi A; Binns C; Dhaliwal S; Radavelli-Bagatini S
Br J Nutr; 2012 Mar; 107(5):725-34. PubMed ID: 21787454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
